Publications by authors named "Erika Naliato"

 The objectives of this study are to compare absolute values of acromial index (AI) and critical shoulder angle (CSA) obtained in both radiographs and magnetic resonance image (MRI) of the shoulder; and to compare the interobserver and intra-observer agreement for AI and CSA values measured in these image modalities.  Patients who had medical indication of investigating shoulders conditions through radiographs and MRI were included. Images were taken to two fellowship-trained shoulder surgeons, which conducted measurements of AI and CSA in radiographs and in MRI.

View Article and Find Full Text PDF

Composite pheochromocytoma (CP) is a very rare tumor originating from neural crest cells, predominantly composed of pheochromocytoma (PCC), a chromaffin cell tumor arising in adrenal medulla, and ganglioneuroma, a tumor derived from autonomic ganglion cells of the nervous system. Moreover, CP may be present in the hereditary syndromes of which pheochromocytoma is part. Literature offers scarce data on this subject, and particularly about its biological behavior, clinical evolution, and molecular profile.

View Article and Find Full Text PDF

Objective: To evaluate body dissatisfaction and distorted body self-image in women with prolactinoma.

Methods: Body dissatisfaction and distorted body self-image were evaluated in 80 women with prolactinoma. All patients were in menacme, 34% had normal body mass index (BMI), and 66% were overweight.

View Article and Find Full Text PDF

Unlabelled: Tumoral hyperprolactinemia and consequent hypogonadism have been associated with osteoporosis. Bone mineral density (BMD) was measured by dual-energy RX absorptiometry in 24 patients with prolactinoma (15 macro and 9 micro adenomas; age range = 18 to 49 years). Student unpaired t or Mann-Whitney tests were used to compare groups, and Spearman test studied correlations.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess bone density in women with prolactinoma treated with dopamine agonists compared to healthy controls, using DXA scans and biochemical analyses.
  • Women with prolactinoma showed significantly lower lumbar spine Z-scores compared to controls, indicating bone density loss, particularly linked to the duration of amenorrhea.
  • The findings stress the need for effective management of prolactinoma to prevent potential complications related to bone health in affected women.
View Article and Find Full Text PDF
Article Synopsis
  • The study assessed body fat in nonobese women with prolactinoma treated with dopamine agonists using DXA and examined the relationship between body fat, hormone levels, and clinical factors.
  • Women with prolactinoma had similar body fat percentages to control subjects, but those with normal prolactin (PRL) levels showed lower body fat across all evaluated areas.
  • The findings suggest that appropriate dopamine agonist treatment can reduce body fat and lower the risk of Metabolic Syndrome in these patients.
View Article and Find Full Text PDF

Prolactinomas are the most frequent pituitary tumors and may co-secrete GH (growth hormone). IGF-1 (insulin-like growth factor-1) is the main responsible for GH actions and a parameter for the diagnosis of acromegaly. With the objective of identifying through a IGF-1 levels analysis, in the initial evaluation of prolactinoma patients, the existence of mixed tumors [GH and prolactin (PRL)], we studied 7 men and 27 women, aged between 19 and 72 years, confronting them with the results of basal and glucose stimulated (glucose tolerance test--GTT) GH levels, indicated when GH >0.

View Article and Find Full Text PDF

Throughout the years evidence has been accumulated on the morbidity of hyperprolactinemia, particularly in terms of bone mineral density decrease. This complication of hyperprolactinemia affects both women and men. In this paper, we analyze aspects related to bone loss in men with hyperprolactinemia due to prolactinomas: prevalence, clinical relevance, physiopathology, diagnosis and the consequences of the treatment of hyperprolactinemia and hypogonadism on bone mineral density.

View Article and Find Full Text PDF

Macroprolactinomas predominate in males in comparison to microprolactinomas, with greater trend to invasiveness than in females. The clinical treatment has been the first option to prolactinomas, in both macro and microadenomas, irrespective the sex. We compared clinical presentation, prolactin levels, neuroradiologic invasiveness and prolactinemia response of 23 men with prolactinomas subjected to clinical therapy (group 1) with 19 who went also through surgical and/or radiotherapeutic treatment (group 2).

View Article and Find Full Text PDF